COVID-19 Infection in Patients with Chronic Lymphocytic Leukemia Receiving Acalabrutinib in the Phase 3B ASSURE Study

Carsten U. Niemann; Farrukh T. Awan; Laura Fogliatto; Eugene Nikitin; Olga Samoilova; Adel Habib; Kayhan Foroutanpour; Nataliya Kuptsova-Clarkson; Stephen Opat

doi:10.1097/HS9.0000000000000780

COVID-19 Infection in Patients with Chronic Lymphocytic Leukemia Receiving Acalabrutinib in the Phase 3B ASSURE Study

Carsten U. Niemann, Farrukh T. Awan, Laura Fogliatto, Eugene Nikitin, Olga Samoilova, Adel Habib, Kayhan Foroutanpour, Nataliya Kuptsova-Clarkson, Stephen Opat

Research output: Contribution to journal › Article › peer-review

Original language	English (US)
Pages (from-to)	E780
Journal	HemaSphere
Volume	6
Issue number	10
DOIs	https://doi.org/10.1097/HS9.0000000000000780
State	Published - Oct 22 2022
Externally published	Yes

ASJC Scopus subject areas

Hematology

Access to Document

10.1097/HS9.0000000000000780

Cite this

@article{9eaa384bed894a5eabb2fa0403107bc1,

title = "COVID-19 Infection in Patients with Chronic Lymphocytic Leukemia Receiving Acalabrutinib in the Phase 3B ASSURE Study",

author = "Niemann, {Carsten U.} and Awan, {Farrukh T.} and Laura Fogliatto and Eugene Nikitin and Olga Samoilova and Adel Habib and Kayhan Foroutanpour and Nataliya Kuptsova-Clarkson and Stephen Opat",

note = "Funding Information: Writing and editorial assistance were provided by Robert J. Schoen, PharmD, and Laura L. McCormick, PhD, of Peloton Advantage, an OPEN Health company, and funded by AstraZeneca. ",

year = "2022",

month = oct,

day = "22",

doi = "10.1097/HS9.0000000000000780",

language = "English (US)",

volume = "6",

pages = "E780",

journal = "HemaSphere",

issn = "2572-9241",

publisher = "Wolters Kluwer Health",

number = "10",

}

TY - JOUR

T1 - COVID-19 Infection in Patients with Chronic Lymphocytic Leukemia Receiving Acalabrutinib in the Phase 3B ASSURE Study

AU - Niemann, Carsten U.

AU - Awan, Farrukh T.

AU - Fogliatto, Laura

AU - Nikitin, Eugene

AU - Samoilova, Olga

AU - Habib, Adel

AU - Foroutanpour, Kayhan

AU - Kuptsova-Clarkson, Nataliya

AU - Opat, Stephen

N1 - Funding Information: Writing and editorial assistance were provided by Robert J. Schoen, PharmD, and Laura L. McCormick, PhD, of Peloton Advantage, an OPEN Health company, and funded by AstraZeneca.

PY - 2022/10/22

Y1 - 2022/10/22

UR - http://www.scopus.com/inward/record.url?scp=85148937657&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85148937657&partnerID=8YFLogxK

U2 - 10.1097/HS9.0000000000000780

DO - 10.1097/HS9.0000000000000780

M3 - Article

C2 - 36168519

AN - SCOPUS:85148937657

SN - 2572-9241

VL - 6

SP - E780

JO - HemaSphere

JF - HemaSphere

IS - 10

ER -

COVID-19 Infection in Patients with Chronic Lymphocytic Leukemia Receiving Acalabrutinib in the Phase 3B ASSURE Study

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this